Thursday, February 16, 2023 1:22:22 PM
The new data covers 52 weeks ending 1/29/2023. Comparing this data to 52 weeks ending 10/22/2022 shows the following
fastest growing sku's
Pluscbd SLEEP $66,481 (Oct.22) $79,001(Jan.2023)
Pluscbd CALM $62,179 (OCT. 22) $70.260 (Jan.2023)
Pluscbd RESERVE peach $44,261 (Oct.22) $58,022 (Jan. 2023)
Pluscbd Reserve watermelon $43,592 $58,224 (Jan 2023)
So with the help of these 4 sku's in the top 10 sku's, sales have increased for the first time in 2 years overall
from $638k (Oct "22) to $641K (Jan 2023)
Okay to the cvsi detractors this isn't much but it may indicate the decline has stopped.
Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:54:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 01:28:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM